Table 1: Patient preoperative and intraoperative demographic characteristics.
Group A uterine cavity 4-6.5 cm | Group B uterine cavity > 6.5 | |||
Mean (SD) | Mean (SD) | t | p | |
Age | 44.1 (5.2) | 45.0 (6.0) | -0.49 | 0.53 |
Parity* | 2.1 (0.9) | 2.6 (1.9) | -1.35 | 0.015 |
Preoperative US uterine volume* | 116.3 (43.8) | 206.9 (106.6) | -4.54 | < 0.001 |
Length of uterine cavity (cm)* | 5.4 (0.6) | 7.1 (0.2) | -8.30 | 0.005 |
Width of uterine cavity (cm)* | 4.0 (0.7) | 4.4 (0.4) | -1.8 | 0.048 |
N (%) | N (%) | X2 | P | |
Nulliparous | 6 (7.1) | 1 (11.1) | 0.26 | 0.61 |
Vaginal delivery only | 61 (69.3) | 4 (44.4) | 2.27 | 0.13 |
Caesarean section | 22 (25) | 2 (22.2) | 2.75 | 0.43 |
Heavy menstrual periods only | 59 (67.0) | 4 (44.4) | 1.84 | 0.18 |
Heavy menstrual periods and dysmenorrhea | 29 (32.9) | 5 (55.6) | ||
Adenomyosis (n = 93) | 18 (20.5) | 3 (33.3) | 1.49 | 0.49 |
Previous mirena IUD failure | 14 (15.9) | 3 (33.3) | 1.87 | 0.17 |
Mirena IUD insertion or replacement intraoperatively | 6 (6.8) | 0 (0.0) | 0.63 | 0.43 |
Mirena IUD replaced intraoperatively | 3 (3.4) | 1 (11.1) | 1.30 | 0.25 |
Submucous fibroids^ (n = 93) | 7 (8) | 0 (0.0) | 0.81 | 0.37 |
Fibroids (excluding submucous) (n = 92), #* | 20 (22.7) | 5 (55.6) | 4.06 | 0.04 |
Intrauterine polyps$ (n = 93) | 10 (11.7) | 1 (11.1) | 0.005 | 0.94 |
^Diagnosed on US or intraoperatively; #Diagnosed on preoperative US; $-Diagnosed on US or intraoperatively; *p = < 0.05.